WEEKEND READER: Learning To Live With Forever COVID
The virus might be with us forever — so it’s time to get real about what that means.
The virus might be with us forever — so it’s time to get real about what that means.
From the launch of a worker-owned Appeal to a Jacobin-crafted board game, journalists are scoring wins.
On this week’s Daily Poster/Breaking Points discussion, Andrew Perez discusses Sinema’s new Big Pharma reward for gutting Dems’ drug pricing plan.
Can Democrats break from their corporate donors and learn from their past mistakes?
The GOP-led Congressional Budget Office is using gimmicks and fuzzy math to doom the Democrats’ Build Back Better bill.
Critics say it’s too easy for anti-vaxxers to exploit loopholes in OSHA’s new COVID-19 workplace vaccination requirements.
By refusing to define “climate finance,” the U.S. and other developed nations are avoiding their environmental responsibilities and forcing other nations into debt traps.
A front group funded by Big Pharma is running more ads praising Kyrsten Sinema, who just gutted Dems’ drug pricing plan.
A left-punching New York Times essay shows how corporate media boosts a particular ideology.
On this week’s Daily Poster/Breaking Points discussion, Sirota discusses why popularity doesn’t matter.